Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.
Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2010 sales were more than $2.6 billion.
Merial is a Sanofi company. For more information, please see www.merial.com
Merial is the world's leading animal health company. We're a "young" and forward-looking company with a proven track record, producing pharmaceutical products and vaccines for livestock, pets and wildlife.
We're at the cutting edge of product development and innovation, providing millions of doses world-wide annually to keep livestock and pets healthy.
Our Vision & Values
Merial - Our Vision
We will be an innovation-driven leader in the provision of products and solutions which enhance the health, well-being, and performance of animals.
Merial - Our Values
Merial is a world-leading animal health company. We maintain our position as a world leader because we are committed to the following values:
- Focusing on the Customer
- Respecting People
- Acting with Integrity
- Promoting Innovation
- Fostering Empowerment
- Supporting Teamwork
- Committed to Performance
- What is Merial's business?
- What is Merial’s vision?
- When was Merial founded?
- How many people are employed by Merial?
- What are Merial’s total sales?
- Who leads Merial's senior management team?
- Who are Merial’s shareholders?
- Does Merial have a stock market listing?
- What are Merial’s leading products?
- In which countries does Merial operate?
- What is Merial’s main customer base?
- What is Merial’s R & D focus?
A. Merial is an innovation-driven leader in the provision of products and solutions that enhance the health, well-being and performance of animals.
A. Merial was founded in August 1997 through the merger of the animal health businesses of Merck and Co., Inc. and Rhone Merieux, a predecessor to sanofi-aventis
A. Merial employs more than 5,700 people worldwide.
A. Total 2008 sales were nearly $2.6 billion.
A. Jose Barella is the Executive Chairman
A. No. Merial is a fully-integrated, free standing company separately owned by sanofi-aventis, which is listed on the New York Stock Exchange and the Paris Stock Exchange.
A. Merial has leading products in a wide range of veterinary specialties, notably in the fields of antiparasitic, antimicrobial, gastrointestinal, respiratory and cardiovascular medicines, and produces a range of vaccines to protect a wide variety of species against disease.
Merial's best known products are probably their best selling antiparasitics. IVOMEC® (ivermectin) -- which was first launched in 1981 for treatment and protection against parasites in large animals such as cattle, sheep and swine ---- is the world’s single most successful animal health product.
Merial’s pharmaceuticals are supported by a wide range of vaccines. We are specialists in the area of avian protection, offering a range of vaccines to protect birds, particularly poultry, against a range of common and life-threatening diseases such as Newcastle Disease, Marek's Disease and Avian Flu. Merial is also well-known for its antirabies vaccines for use in domestic and wild animals and for its foot and mouth disease vaccine, which was pioneered by the Institut Mérieux the French forerunner of the present company.
A. Merial’s customers include veterinarians, pet owners, farmers and food animal producers worlwide.
A. Merial is advancing in four main areas: parasiticides, antibiotics, pain control, and products for treating chronic conditions in companion animals. We are also exploring and developing new ranges of vaccines which employ both conventional and novel technologies with the objective of offering enhanced protection to a wide range of animal species